Anna Protopapas's Net Worth

$7.81 Million

Estimate Recalculated Jul 2, 2024 04:20PM EST

Who is Anna Protopapas?

Anna Protopapas has an estimated net worth of $7.81 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, Nuvalent, Inc., Mersana Therapeutics, Inc., Bioverativ Inc., ARIAD PHARMACEUTICALS INC, and MILLENNIUM PHARMACEUTICALS INC.

SEC CIK

Anna Protopapas's CIK is 0001347582

Past Insider Trading and Trends

2007 was Anna Protopapas's most active year for acquiring shares with 17 total transactions. Anna Protopapas's most active month to acquire stocks was the month of December. 2007 was Anna Protopapas's most active year for disposing of shares, totalling 29 transactions. Anna Protopapas's most active month to dispose stocks was the month of April. 2017 saw Anna Protopapas paying a total of $1,869,602.97 for 149,750 shares, this is the most they've acquired in one year. In 2008 Anna Protopapas cashed out on 443,879 shares for a total of $4,583,256.28, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dicerna Pharmaceuticals Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3.33K
—
—
3.33K
Jun 3
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jan 23
Form 3
—
0
—
—
0
No matching records found

Nuvalent, Inc. (NUVL) Snapshot price: $79.33

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.5K
—
—
2.5K
Jun 12
Form 4
—
0
$42.52
-$331,550.00
0
Dec 18
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Mar 30
Form 3
—
0
—
—
0
No matching records found

Mersana Therapeutics, Inc. (MRSN) Snapshot price: $3.535

President & CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 11
Form 4
+85.15%
57.56K
$2.71
-$79,671.29
125.15K
Scheduled
Jan 13 - Jan 16
Form 4
+32.66%
16.64K
—
—
67.59K
Sep 11
Form 4
+15.31%
38.36K
$5.74
-$99,566.04
288.98K
May 20 - Jan 17
Form 4
+13.72%
38.96K
—
—
322.88K
Jan 14
Form 4
+25.81%
58.06K
$12.24
-$513,186.23
282.98K
Jul 15 - Jul 19
Form 4
+5.89%
12.51K
$21.09
-$109,625.82
224.92K
Jan 15
Form 4
—
0
—
—
0
Jan 15
Form 4
—
0
—
—
0
Jul 17
Form 4
—
0
—
—
0
Jan 23
Form 4
—
0
—
—
0
Feb 2
Form 4
+8.66%
10.42K
$1.53
$15,938.01
130.72K
Dec 20
Form 4
+60.07%
72.26K
—
—
192.56K
Jul 3
Form 3
—
0
—
—
0
No matching records found

Bioverativ Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.06K
—
—
0
Mar 8
Form 4
—
0
—
—
0
Jan 31
Form 4
∞
1.06K
$56.83
$60,012.48
1.06K
Apr 17
Form 4
—
0
—
—
0
Feb 28
Form 3
—
0
—
—
0
No matching records found

ARIAD PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-41.91K
—
—
0
Feb 16
Form 4
+75.34%
18.01K
—
—
41.91K
Jan 31
Form 4
∞
23.9K
—
—
23.9K
Feb 1
Form 4
—
0
—
—
0
Apr 28
Form 3
—
0
—
—
0
No matching records found